StreetInsider.com News Articles

Form 4 Orthofix Medical Inc. For: Oct 01 Filed by: Fisher Patrick

Mon, 05 Oct 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20261005/27149053.html

Form 4/A Orthofix Medical Inc. For: Sep 18 Filed by: MICHAS ALEXIS P

Wed, 23 Sep 2026 15:52:00 -0400

si-local-file:///var/storage/secattach/20260923/27096581.html

Form 4 Orthofix Medical Inc. For: Sep 18 Filed by: Juniper Investment Company, LLC

Tue, 22 Sep 2026 16:26:00 -0400

si-local-file:///var/storage/secattach/20260922/27091365.html

Orthofix Medical (OFIX) Reiterated at Buy by Stifel

Tue, 15 Sep 2026 07:23:32 -0400

Stifel analyst Thomas M. Stephan reiterated a Buy rating and $13.00 price target on Orthofix Medical (NASDAQ: OFIX).

The analyst commented, "We believe profitable growth at an attractive valuation makes it easier to own OFIX for key drivers like long-term ET tailwinds benefiting 7D FLASH; improved commercial execution supporting growth; and the limb reconstruction opportunity, where our surgeon checks have been encouraging."

For an analyst ratings summary and ratings history on Orthofix Medical click here. For more ratings news on Orthofix Medical click here.

Shares of Orthofix Medical closed at $9.11 yesterday.

Form 4 Orthofix Medical Inc. For: Aug 18 Filed by: Fisher Patrick

Thu, 20 Aug 2026 17:04:00 -0400

si-local-file:///var/storage/secattach/20260820/26957094.html

Form 4 Orthofix Medical Inc. For: Aug 18 Filed by: Fisher Patrick

Thu, 20 Aug 2026 17:04:00 -0400

si-local-file:///var/storage/secattach/20260820/26957094.html

Form 4 Orthofix Medical Inc. For: Aug 14 Filed by: Juniper Investment Company, LLC

Tue, 18 Aug 2026 17:05:00 -0400

si-local-file:///var/storage/secattach/20260818/26945305.html

Form 4 Orthofix Medical Inc. For: Aug 14 Filed by: Juniper Investment Company, LLC

Tue, 18 Aug 2026 17:05:00 -0400

si-local-file:///var/storage/secattach/20260818/26945305.html

Form SCHEDULE 13G/A Orthofix Medical Inc. Filed by: ARMISTICE CAPITAL, LLC

Fri, 14 Aug 2026 10:23:00 -0400

si-local-file:///var/storage/secattach/20260814/26926353.html

Form SCHEDULE 13G/A Orthofix Medical Inc. Filed by: ARMISTICE CAPITAL, LLC

Fri, 14 Aug 2026 10:23:00 -0400

si-local-file:///var/storage/secattach/20260814/26926353.html

Orthofix Medical (OFIX) PT Lowered to $13 at Canaccord

Mon, 10 Aug 2026 07:00:59 -0400

Canaccord analyst Caitlin Burrows lowered the price target on Orthofix Medical (NASDAQ: OFIX) to $13.00 (from $18.00) while maintaining a Buy rating.

Form S-8 Orthofix Medical Inc.

Wed, 05 Aug 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260805/26874118.html

Form S-8 Orthofix Medical Inc.

Wed, 05 Aug 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260805/26874118.html

Orthofix Medical (OFIX) PT Lowered to $13 at Stifel

Wed, 05 Aug 2026 15:03:25 -0400

Stifel analyst Thomas M. Stephan lowered the price target on Orthofix Medical (NASDAQ: OFIX) to $13.00 (from $15.00) while maintaining a Buy rating.

Orthofix International (OFIX) Tops Q2 EPS by 1c; Offers Guidance

Wed, 05 Aug 2026 09:01:32 -0400

Orthofix International (NASDAQ: OFIX) reported Q2 EPS of ($0.39), $0.01 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $210.93 million versus the consensus estimate of $209.28 million.

FY2026 Outlook-

Revenue between $845 million to $855 million versus the consensus $843.3 million.

For earnings history and earnings-related data on Orthofix International (OFIX) click here.

Form 10-Q Orthofix Medical Inc. For: Jun 30

Wed, 05 Aug 2026 07:06:00 -0400

si-local-file:///var/storage/secattach/20260805/26870154.html

Form 10-Q Orthofix Medical Inc. For: Jun 30

Wed, 05 Aug 2026 07:06:00 -0400

si-local-file:///var/storage/secattach/20260805/26870154.html

Form 8-K Orthofix Medical Inc. For: Aug 05

Wed, 05 Aug 2026 07:04:00 -0400

si-local-file:///var/storage/secattach/20260805/26870119.html

Form 8-K Orthofix Medical Inc. For: Aug 05

Wed, 05 Aug 2026 07:04:00 -0400

si-local-file:///var/storage/secattach/20260805/26870119.html

Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress